GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (HKSE:02142) » Definitions » PS Ratio

HBM Holdings (HKSE:02142) PS Ratio : 20.18 (As of Apr. 23, 2025)


View and export this data going back to 2020. Start your Free Trial

What is HBM Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, HBM Holdings's share price is HK$7.85. HBM Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.39. Hence, HBM Holdings's PS Ratio for today is 20.18.

The historical rank and industry rank for HBM Holdings's PS Ratio or its related term are showing as below:

HKSE:02142' s PS Ratio Range Over the Past 10 Years
Min: 1.11   Med: 8.02   Max: 194.55
Current: 20.18

During the past 7 years, HBM Holdings's highest PS Ratio was 194.55. The lowest was 1.11. And the median was 8.02.

HKSE:02142's PS Ratio is ranked worse than
69.65% of 972 companies
in the Biotechnology industry
Industry Median: 8.38 vs HKSE:02142: 20.18

HBM Holdings's Revenue per Sharefor the six months ended in Jun. 2024 was HK$0.25. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.39.

Warning Sign:

HBM Holdings Ltd revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of HBM Holdings was 32.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 100.20% per year.

During the past 7 years, HBM Holdings's highest 3-Year average Revenue per Share Growth Rate was 99.10% per year. The lowest was 14.80% per year. And the median was 45.30% per year.

Back to Basics: PS Ratio


HBM Holdings PS Ratio Historical Data

The historical data trend for HBM Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings PS Ratio Chart

HBM Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial 17.23 167.39 6.47 2.06 4.91

HBM Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.47 - 2.06 - -

Competitive Comparison of HBM Holdings's PS Ratio

For the Biotechnology subindustry, HBM Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HBM Holdings's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where HBM Holdings's PS Ratio falls into.


;
;

HBM Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

HBM Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=7.85/0.389
=20.18

HBM Holdings's Share Price of today is HK$7.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HBM Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.39.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


HBM Holdings  (HKSE:02142) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


HBM Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of HBM Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HBM Holdings Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, Suite 202, Building A3, Suzhou Industrial Park, Suzhou, CHN, 215123
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Wang Jingsong 2101 Beneficial owner
Advantech Capital L.p.
Pang Kee Chan Hebert
Golden Link Investment Limited
Advantech Capital Partners Ltd.
Advantech Master Investment Limited
Astrazeneca Plc 2201 Interest of corporation controlled by you
Gic Private Limited 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
Gic Special Investments Private Limited 2102 Investment manager
Owap Investment Pte Ltd 2101 Beneficial owner
Advantech Capital Holdings Ltd.
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

HBM Holdings Headlines

No Headlines